Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
SCT-200 by SinoCelltech Group for Colorectal Cancer: Likelihood of Approval
SCT-200 is under clinical development by SinoCelltech Group and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase...
SCT-200 by SinoCelltech Group for Metastatic Colorectal Cancer: Likelihood of Approval
SCT-200 is under clinical development by SinoCelltech Group and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData,...
Coronavirus Disease 2019 (Covid-19) [Alpha/Beta] (Bivalent) Vaccine by SinoCelltech Group for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
Coronavirus Disease 2019 (Covid-19) [Alpha/Beta] (Bivalent) Vaccine is under clinical development by SinoCelltech Group and currently in Phase III for...